Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
FDA approval
Pharma
Orca Bio takes commercial leap with FDA approval for Tregzi
Orca Bio is charging the WAC of $428,000 for Tregzi, a novel regulatory T cell-based therapy for blood cancer patients requiring transplants.
Angus Liu
Jul 1, 2026 12:14am
Viridian set for 1-on-1 vs. Amgen after FDA approval of Lumvoa
Jun 29, 2026 8:32am
FDA approves GSK, Spero's oral treatment for complicated UTIs
Jun 17, 2026 3:20pm
Shionogi's Japan-approved antiviral nets US COVID nod
Jun 1, 2026 11:11am
FDA signs off on pediatric expansion for MannKind's Afrezza
May 29, 2026 12:55pm
AZ gains on Merck with 2nd bladder cancer nod for Imfinzi
May 28, 2026 4:39pm
